What are the appropriate acute and preventive medication options for an adult with typical episodic migraine without aura?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Migraine Medications: Acute and Preventive Treatment

For acute treatment of moderate to severe episodic migraine, start with combination therapy of a triptan plus an NSAID (such as sumatriptan with naproxen), taken as early as possible at headache onset. 1 For prevention, begin with a β-blocker (metoprolol or propranolol), valproate, venlafaxine, or amitriptyline before considering newer CGRP-targeted therapies. 2

Acute Treatment Algorithm

First-Line: Mild Migraine

  • NSAID monotherapy (ibuprofen, naproxen, diclofenac, aspirin, or celecoxib) or acetaminophen 1
  • Combination of NSAID + acetaminophen is also appropriate 1

First-Line: Moderate to Severe Migraine

Combination therapy is superior to monotherapy. Use triptan + NSAID or triptan + acetaminophen (when NSAIDs contraindicated). 1 High-certainty evidence shows this combination produces:

  • 180 more people per 1000 achieving sustained pain relief at 48 hours
  • 160 fewer people per 1000 requiring rescue medication 1

Specific triptan options (choose based on route preference and cost): almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, or zolmitriptan 1

Critical timing: Treat immediately at headache onset with combination therapy for maximum efficacy 1

Second-Line: Inadequate Response to Triptans

If combination triptan + NSAID/acetaminophen fails, consider:

  • CGRP antagonists (gepants): rimegepant, ubrogepant, or zavegepant 1
  • Ergot alkaloid: dihydroergotamine 1

Third-Line: Refractory Cases

  • Lasmiditan (5-HT1F agonist) for patients who fail all other treatments 1
  • This is particularly valuable for patients with cardiovascular contraindications to triptans 3

Special Situations

  • Severe nausea/vomiting: Use nonoral triptan formulation + antiemetic 1
  • Never use: Opioids or butalbital-containing medications 1

Critical Pitfall: Medication Overuse Headache

Monitor frequency carefully:

  • NSAIDs: ≥15 days/month triggers medication overuse headache
  • Triptans: ≥10 days/month triggers medication overuse headache 1

If approaching these thresholds, initiate preventive therapy immediately.


Preventive Treatment Algorithm

Indications for prevention: Severe debilitating headaches despite adequate acute treatment, contraindications to acute therapy, or overuse of acute medications 2

First-Line Preventive Options (Choose One)

Start with these cost-effective, evidence-based options before newer agents:

  • β-blockers: metoprolol or propranolol
  • Antiseizure medication: valproate
  • SNRI: venlafaxine
  • TCA: amitriptyline 2

Dosing strategy: Start low, titrate gradually until desired effect achieved. Allow 2-3 months for adequate trial before switching. 2

Second-Line: After First-Line Failure

If inadequate response or intolerance to above medications:

  • CGRP antagonist (gepant): atogepant or rimegepant 2
  • CGRP monoclonal antibodies: eptinezumab, erenumab, fremanezumab, or galcanezumab 2

Rationale for sequencing: β-blockers and CGRP-mAbs show similar small net benefit compared to topiramate, but topiramate has higher adverse event frequency. Cost considerations favor trying traditional agents first. 2

Third-Line: Topiramate

Use only after trials of first-line agents AND gepant/CGRP-mAb have failed, due to higher adverse event profile 2

Alternative Options (If Standard Agents Fail)

  • ACE inhibitor: lisinopril
  • ARBs: candesartan or telmisartan
  • SSRI: fluoxetine 2

Preventive Treatment Principles

  • Adherence is crucial: Effects appear gradually over first few weeks 2
  • Trial duration: 2-3 months minimum before declaring failure 2
  • Cost matters: Actual treatment costs vary significantly (traditional agents ~$500/year vs. gepants/CGRP-mAbs ~$6000/year), so assess individual economic circumstances 2
  • Headache diary: Use to determine efficacy, identify analgesic overuse, monitor progression 2

Essential Lifestyle Modifications (All Patients)

Address these before or concurrent with pharmacotherapy:

  • Maintain hydration
  • Regular, adequate sleep schedule
  • Regular physical activity (moderate to intense aerobic exercise preferred)
  • Consistent meal timing
  • Stress management (relaxation techniques, mindfulness)
  • Weight loss if overweight/obese
  • Identify and modify specific migraine triggers 1

Special Population: Pregnancy/Lactation

Acute treatment during pregnancy:

  • Safest: acetaminophen
  • Option: acetaminophen with codeine
  • Selected patients: sumatriptan may be considered
  • Sumatriptan is compatible with breastfeeding 4

Preventive treatment: Discuss adverse effects of all pharmacologic treatments with patients of childbearing potential. Valproate carries significant teratogenic risk. 2, 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.